DYN icon

Dyne Therapeutics

113 hedge funds and large institutions have $571M invested in Dyne Therapeutics in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

9% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% less capital invested

Capital invested by funds: $573M → $571M (-$1.79M)

Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$860K
Puts
$49K
Net Calls
Net Calls Change

Top Buyers

1 +$26.9M
2 +$10.8M
3 +$5.81M
4
Goldman Sachs
Goldman Sachs
New York
+$5.08M
5
Axa
Axa
France
+$4.27M

Top Sellers

1 -$19.5M
2 -$5.79M
3 -$2.24M
4
LGM
Logos Global Management
California
-$1.59M
5
Citigroup
Citigroup
New York
-$1.35M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$9K
102
$7.07K
103
$6.14K
104
$5.28K
105
$4.64K
106
$2.73K
107
$2.21K
108
$2K
109
$1.45K
110
$1.19K
111
$1K
112
$707
113
114
115
116
117
118
119
120
121